• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性输血对一名无脾血红蛋白E/β地中海贫血患者高凝状态的纠正及肺动脉高压的改善作用

Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patient.

作者信息

Atichartakarn Vichai, Chuncharunee Suporn, Chandanamattha Pakorn, Likittanasombat Khanchit, Aryurachai Katcharin

机构信息

Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Blood. 2004 Apr 1;103(7):2844-6. doi: 10.1182/blood-2003-09-3094. Epub 2003 Nov 26.

DOI:10.1182/blood-2003-09-3094
PMID:14645000
Abstract

Chronic transfusion of packed red blood cells, in addition to other ongoing treatment with warfarin, acetyl salicylic acid, desferrioxamine, and other supportive measures, was given to a splenectomized hemoglobin E/beta-thalassemia woman with pulmonary arterial hypertension (PHT). Serial measurements of plasma thrombin-antithrombin III complex (TAT) levels and right-sided cardiac catheterization were used to monitor changes after treatment. Reduction of plasma TAT levels from 7.5 to 3.8 microg/L (normal, 3 +/- 2.4 microg/L), pulmonary vascular resistance (PVR) from 553.8 to 238.6 dyne.sec.cm(-5) (normal, 67 +/- 30 dyne.sec.cm(-5)), and mean pulmonary arterial pressure from 51 to 32 mm Hg (normal, 9 to 19 mm Hg) occurred in tandem. Normalization of blood hypercoagulability as reflected in plasma TAT level by chronic blood transfusion was the likely basis for improvement of increased PVR, being secondary to thrombotic pulmonary arteriopathy and subsequently PHT.

摘要

除了使用华法林、乙酰水杨酸、去铁胺进行其他持续治疗以及采取其他支持措施外,还给一位接受脾切除的血红蛋白E/β地中海贫血且患有肺动脉高压(PHT)的女性长期输注浓缩红细胞。采用连续测量血浆凝血酶 - 抗凝血酶III复合物(TAT)水平及右侧心导管检查来监测治疗后的变化。血浆TAT水平从7.5降至3.8μg/L(正常范围为3±2.4μg/L),肺血管阻力(PVR)从553.8降至238.6达因·秒·厘米⁻⁵(正常范围为67±30达因·秒·厘米⁻⁵),平均肺动脉压从51降至32mmHg(正常范围为9至19mmHg),这些变化同步发生。长期输血使血浆TAT水平所反映的血液高凝状态恢复正常,这可能是PVR升高得到改善的基础,PVR升高继发于血栓形成性肺动脉病,进而导致PHT。

相似文献

1
Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patient.慢性输血对一名无脾血红蛋白E/β地中海贫血患者高凝状态的纠正及肺动脉高压的改善作用
Blood. 2004 Apr 1;103(7):2844-6. doi: 10.1182/blood-2003-09-3094. Epub 2003 Nov 26.
2
Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders.既往行脾切除术的β地中海贫血症患者的肺动脉高压
Int J Hematol. 2003 Aug;78(2):139-45. doi: 10.1007/BF02983382.
3
Correction of coagulation and inflammation activation by chronic blood transfusion in an asplenic patient with haemoglobin E/β-thalassaemia and pulmonary arterial hypertension.
Transfus Med. 2013 Aug;23(4):276-8. doi: 10.1111/tme.12025. Epub 2013 Mar 11.
4
Vascular and hemostatic alterations associated with pulmonary hypertension in β-thalassemia hemoglobin E patients receiving regular transfusion and iron chelation.β-地中海贫血合并血红蛋白 E 患者接受规律输血和铁螯合治疗后与肺动脉高压相关的血管和止血改变。
Thromb Res. 2019 Feb;174:104-112. doi: 10.1016/j.thromres.2018.12.021. Epub 2018 Dec 20.
5
Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent β-thalassemia/HbE patients with pulmonary arterial hypertension.依赖输血的β-地中海贫血/血红蛋白 E 合并肺动脉高压患者血小板和红细胞衍生的细胞外囊泡水平升高。
Ann Hematol. 2019 Feb;98(2):281-288. doi: 10.1007/s00277-018-3518-z. Epub 2018 Oct 18.
6
Cardiac involvement in thalassemia intermedia: a multicenter study.中间型地中海贫血的心脏受累:一项多中心研究。
Blood. 2001 Jun 1;97(11):3411-6. doi: 10.1182/blood.v97.11.3411.
7
Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E/β-thalassemia disease.血红蛋白E/β地中海贫血患者肺动脉高压的患病率及危险因素
Eur J Haematol. 2014 Apr;92(4):346-53. doi: 10.1111/ejh.12242. Epub 2014 Jan 10.
8
Pulmonary hypertension in beta-thalassemia.β地中海贫血中的肺动脉高压。
Ann N Y Acad Sci. 2005;1054:342-9. doi: 10.1196/annals.1345.041.
9
Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.肝移植术中一例门肺高压患者的体外膜肺氧合挽救治疗:病例报告
Transplant Proc. 2013 Sep;45(7):2774-5. doi: 10.1016/j.transproceed.2013.07.001.
10
Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia.中间型β地中海贫血患者的肺动脉高压和右心衰竭
Chest. 1995 Jan;107(1):50-3. doi: 10.1378/chest.107.1.50.

引用本文的文献

1
Green Tea Epigallocatechin 3-Gallate Reduced Platelet Aggregation and Improved Anticoagulant Proteins in Patients with Transfusion-Dependent β-Thalassemia: A Randomized Placebo-Controlled Clinical Trial.绿茶表没食子儿茶素3-没食子酸酯降低输血依赖型β地中海贫血患者的血小板聚集并改善抗凝蛋白:一项随机安慰剂对照临床试验
Foods. 2024 Nov 29;13(23):3864. doi: 10.3390/foods13233864.
2
The Characteristics of Compound Heterozygosity for Hemoglobin G-Makassar with Hb E in Malaysia.马来西亚血红蛋白G-望加锡与血红蛋白E复合杂合性的特征
J Blood Med. 2024 May 29;15:255-264. doi: 10.2147/JBM.S432849. eCollection 2024.
3
Prognostic Role of Multiparametric Cardiac Magnetic Resonance in Neo Transfusion-Dependent Thalassemia.
多参数心脏磁共振成像在新输血依赖型地中海贫血中的预后作用
J Clin Med. 2024 Feb 23;13(5):1281. doi: 10.3390/jcm13051281.
4
An update on recent studies of extracellular vesicles and their role in hypercoagulability in thalassemia (Review).地中海贫血中细胞外囊泡及其在高凝状态中作用的近期研究进展(综述)
Biomed Rep. 2023 Dec 28;20(2):31. doi: 10.3892/br.2023.1719. eCollection 2024 Feb.
5
Economic burden of Thalassemia treatment: An analysis from the Vietnam Social Security perspective.地中海贫血治疗的经济负担:从越南社会保障角度的分析。
PLoS One. 2023 Nov 27;18(11):e0293916. doi: 10.1371/journal.pone.0293916. eCollection 2023.
6
Macitentan Administration for Pulmonary Hypertension Due to β-thalassemia with Multiple Organ Failure.马昔腾坦治疗β-地中海贫血所致肺高血压伴多器官功能衰竭。
Intern Med. 2024 Jun 1;63(11):1585-1590. doi: 10.2169/internalmedicine.2307-23. Epub 2023 Nov 13.
7
How I treat non-transfusion-dependent β-thalassemia.我如何治疗非输血依赖型β-地中海贫血。
Blood. 2023 Sep 14;142(11):949-960. doi: 10.1182/blood.2023020683.
8
Phosphatidylserine-exposed red blood cells and ineffective erythropoiesis biomarkers in patients with thalassemia.地中海贫血患者中暴露磷脂酰丝氨酸的红细胞及无效红细胞生成生物标志物
Am J Transl Res. 2022 Jul 15;14(7):4743-4756. eCollection 2022.
9
High Prevalence of Antiphospholipid Antibodies in Children with NonTransfusion Dependent Thalassemia and Possible Correlations with Microparticles.非输血依赖型地中海贫血患儿抗磷脂抗体的高流行率及其与微粒的可能相关性
Mediterr J Hematol Infect Dis. 2020 Nov 1;12(1):e2020071. doi: 10.4084/MJHID.2020.071. eCollection 2020.
10
Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand.成人地中海贫血患者疾病相关并发症及处理的综述:泰国多中心研究。
PLoS One. 2019 Mar 20;14(3):e0214148. doi: 10.1371/journal.pone.0214148. eCollection 2019.